Skip to content
o2h discovery logo

o2h discovery website

o2h discovery – seeding new ideas in life science, tech and green …

o2h discovery logo
  • about
    • company overview
    • team
    • ESG
    • o2h community
  • how we deliver
  • news & insights
    • news & press releases
    • blogs
    • posters
    • newsletters
    • white papers
  • events
    • exhibiting/attending events
    • o2h Innovation Conference 2025
    • Bootcamps
    • AIM squad
    • Cambridge Wide Open Day
    • Cambridge TechBIO Caucus
    • Biotech Bikers
    • o2h Chaitime Webinar
  • culture & careers
  • CITCTM
  • o2h group
  • integrated(drug discovery)
    • Target Identification and Validation
    • Hit Identification
    • Hit to Lead
    • Lead Optimization
    • Targeted protein degradation
    • Fragment-based Drug Discovery
    • Knowledge-based drug design and SAR
    • Early assessment of in vitro ADMET and PK
  • chemistry
    • Medicinal Chemistry Services
    • synthetic chemistry
    • peptide synthesis service
    • PROTAC Services
    • Lipid Nanoparticles (LNPs)
    • analytical chemistry
    • ADCs – linker/payloads
    • catalog
  • biology
    • target engagement and validation
      • PROTAC
      • NanoBRET/NanoBiT
      • NaLTSA
      • CRISPR/Cas9
      • siRNA/shRNA
      • Undruggable targets and genetic benchmarking
    • Assay biology
      • Biophysical
      • Biochemical
      • Cellular
      • Gene expression
      • Drug-Drug interactions and synthetic lethality
      • Biomarker assessment
      • Site-directed mutagenesis & binding studies
    • Drug Screening
      • Iterative screening
      • Primary, orthogonal and selectivity
      • Fragment-based screening
      • Phenotypic screening
    • Biology Insights
      • Biochemistry
      • RNA Binding Small Molecule
      • High-Content Imaging
      • Immuno-Oncology Therapeutics
      • Psychedelics
      • Read more…
  • DMPK
    • in-vitro ADME
      • ChamelogK Assay
    • in-vivo Pharmacokinetics (PK)
  • scale-up
    • kilo-lab
    • non-GMP
    • GMP [partnership]
  • models
    • o2h Kickstarter: Global
    • o2h Kickstarter Japan
    • o2h Biology Match Funding
    • o2h Plug-in Biotech
    • o2h Peptide Guarantee
    • o2h Kickstarter: Innovate America
    • o2h discovery Inflexion Tx
    • o2h Platinum Partner
    • o2h Fast Pharma 18
    • Power Your Pipeline With India
  • contact
o2h Kickstarter USA & o2h Exhibiting at Discovery On Target, Boston’ Seeking USA based startups and spin outs to apply for our o2h Kickstarter Award
View this email in your browser


Apply for the o2h kickstarter competition 5.0 - it's live !!!

We have recently announced the launch of the 5th edition of o2h kickstarter, exclusively to support USA based early-stage biotech companies to boost their drug discovery program. The competition is Live now and the recipients are welcome to apply before October 10th…   

The aim of the o2h kickstarter 5.0 is to support the next wave of USA based biotechnology companies that have secured initial funding, have exciting drug targets, and have the ability to scale, but need expert services to supercharge their chemistry efforts to meet the next scientific and funding milestones.

The competition will shortly be closing, so register your interest by clicking the button below.

Best wishes,
Sunil Shah

Register your interest

If you or anyone in your contact list needs to know about this competition, do not hesitate to share it with them and help their start-up get a boost of chemistry…

Forward to Friend Forward to Friend
Competition highlights

Evaluation committee members


If you want to know more about the o2h kickstarter, please click below:
o2h kickstarter


Some of the winners of earlier edition

Upcoming event 

As an integrated #drugdiscovery service provider, we're excited to be exhibiting at the 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐎𝐧 𝐓𝐚𝐫𝐠𝐞𝐭 𝟐𝟎𝟐𝟑 at Boston, MA from 25th-28th Sep 2023. We strive to stay at the forefront of advancements in Protein Degraders and Small Molecules drug discovery research so that we can fully support our pharma and biotech collaborators to progress their novel drug targets which will ultimately benefit human health.

The event promises a dynamic lineup of presentations, delving into the fascinating realms of Protein Degraders, Molecular Glues, Small Molecules Targeting RNA, Proteomics, Genomics, GPCR-Based Drug Discovery, and much more. 

Reach out to Tejas Upadhyay at Booth no. 213, if you are around. We look forward to seeing you!
In case of any queries, please write us at discovery@o2h.com
LinkedIn
Email
Copyright © 2025 o2h group, All rights reserved.
You are connected with o2h discovery with regards to chemistry and biology services and related..

Our mailing address is:
o2h group
The Mill Scitech Park, Hauxton House
Mill Lane, Hauxton
Cambridge, Cambridgeshire CB22 5HX
United Kingdom

Add us to your address book


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

logo-img

o2h discovery private limited.

  • about

    • company overview
    • team
    • culture
    • ESG
  • services

    • Integrated Drug Discovery
    • Fragment-based Drug Discovery
    • Chemistry
    • In-vitro ADME
  • other links

    • news and insights
    • Events
    • o2h community
    • contact
Visit o2h.com o2h discovery
  • social_media_icons
  • social_media_icons
  • social_media_icons
  • social_media_icons

Copyright ©   All rights reserved.

cookies policy privacy policy